Urinary excretion of iPF(2α)-III predicts the risk of future thrombotic events. A 10-year follow-up.
Matteo Nicola Dario
MN
Di Minno
Viviana
V
Cavalca
Armando
A
D'angelo
Isabella
I
Squellerio
Antonio
A
Coppola
Elena
E
Tremoli
Giovanni
G
Di Minno
D000328:Adult; D015415:Biomarkers / Q000652:urine; D005260:Female; D006801:Humans; D015994:Incidence; D028421:Isoprostanes / Q000652:urine*; D007558:Italy / Q000453:epidemiology; D008297:Male; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D016019:Survival Analysis; D015996:Survival Rate; D013927:Thrombosis / Q000175:diagnosis / Q000401:mortality* / Q000652:urine*
D015415:Biomarkers; D028421:Isoprostanes; C438786:isoprostane F2alpha III